support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

View:
format_list_bulletedgrid_view

06/16/2021

CHEPLAPHARM invests in portfolio of anti-infectives
Press releases
Read morechevron_right

05/04/2021

CHEPLAPHARM continues on the road to success
Press releases
Read morechevron_right

04/01/2021

Changes of Management Board per April
Press releases
Read morechevron_right

03/01/2021

Changes of CHEPLAPHARM Management Board per March
Press releases
Read morechevron_right

02/03/2021

CHEPLAPHARM Arzneimittel GmbH Announces Receipt of Required Consents
Investor Relations
Read morechevron_right

02/03/2021

CHEPLAPHARM Arzneimittel GmbH Announces Receipt of Required Consents
Investors Domain
Read morechevron_right

01/26/2021

CHEPLAPHARM Arzneimittel GmbH Announces Consent Solicitation
Investor Relations
Read morechevron_right

01/26/2021

CHEPLAPHARM Arzneimittel GmbH Announces Consent Solicitation
Investors Domain
Read morechevron_right

01/11/2021

CHEPLAPHARM acquires rights to Rivotril®
Investors Domain
Read morechevron_right

01/11/2021

CHEPLAPHARM acquires rights to Rivotril®
Press releases
Read morechevron_right
Back to topexpand_less